Source:http://linkedlifedata.com/resource/pubmed/id/20036131
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
2
|
pubmed:dateCreated |
2010-2-3
|
pubmed:abstractText |
Vesicular monoamine transporter-2 (VMAT2) is a viable target for development of pharmacotherapies for psychostimulant abuse. Lobeline (1) is a potent antagonist at alpha4beta2 * nicotinic acetylcholine receptors, has moderate affinity (K(i)=5.46microM) for VMAT2, and is being investigated currently as a clinical candidate for treatment of psychostimulant abuse. A series of carboxylic acid and sulfonic acid ester analogs 2-20 of lobeline were synthesized and evaluated for interaction with alpha4beta2 * and alpha7 * neuronal nicotinic acetylcholine receptors (nAChRs), the dopamine transporter (DAT), serotonin transporter (SERT) and VMAT2. Both carboxylic acid and sulfonic acid esters had low affinity at alpha7 * nAChRs. Similar to lobeline (K(i)=4nM), sulfonic acid esters had high affinity at alpha4beta2 * (K(i)=5-17nM). Aromatic carboxylic acid ester analogs of lobeline (2-4) were 100-1000-fold less potent than lobeline at alpha4beta2 * nAChRs, whereas aliphatic carboxylic acid ester analogs were 10-100-fold less potent than lobeline at alpha4beta2 *. Two representative lobeline esters, the 10-O-benzoate (2) and the 10-O-benzenesulfonate (10) were evaluated in the (36)Rb(+) efflux assay using rat thalamic synaptosomes, and were shown to be antagonists with IC(50) values of 0.85microM and 1.60microM, respectively. Both carboxylic and sulfonic acid esters exhibited a range of potencies (equipotent to 13-45-fold greater potency compared to lobeline) for inhibiting DAT and SERT, respectively, and like lobeline, had moderate affinity (K(i)=1.98-10.8microM) for VMAT2. One of the more interesting analogs, p-methoxybenzoic acid ester 4, had low affinity at alpha4beta2 * nAChRs (K(i)=19.3microM) and was equipotent with lobeline, at VMAT2 (K(i)=2.98microM), exhibiting a 6.5-fold selectivity for VMAT2 over alpha4beta2 nAChRs. Thus, esterification of the lobeline molecule may be a useful structural modification for the development of lobeline analogs with improved selectivity at VMAT2.
|
pubmed:grant | |
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Esters,
http://linkedlifedata.com/resource/pubmed/chemical/Ligands,
http://linkedlifedata.com/resource/pubmed/chemical/Lobeline,
http://linkedlifedata.com/resource/pubmed/chemical/Neurotransmitter Transport Proteins,
http://linkedlifedata.com/resource/pubmed/chemical/Receptors, Nicotinic
|
pubmed:status |
MEDLINE
|
pubmed:month |
Jan
|
pubmed:issn |
1464-3391
|
pubmed:author | |
pubmed:copyrightInfo |
Copyright 2009 Elsevier Ltd. All rights reserved.
|
pubmed:issnType |
Electronic
|
pubmed:day |
15
|
pubmed:volume |
18
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
640-9
|
pubmed:meshHeading |
pubmed-meshheading:20036131-Animals,
pubmed-meshheading:20036131-Esters,
pubmed-meshheading:20036131-Ligands,
pubmed-meshheading:20036131-Lobeline,
pubmed-meshheading:20036131-Male,
pubmed-meshheading:20036131-Molecular Structure,
pubmed-meshheading:20036131-Neurons,
pubmed-meshheading:20036131-Neurotransmitter Transport Proteins,
pubmed-meshheading:20036131-Rats,
pubmed-meshheading:20036131-Rats, Sprague-Dawley,
pubmed-meshheading:20036131-Receptors, Nicotinic,
pubmed-meshheading:20036131-Stereoisomerism,
pubmed-meshheading:20036131-Structure-Activity Relationship
|
pubmed:year |
2010
|
pubmed:articleTitle |
Lobeline esters as novel ligands for neuronal nicotinic acetylcholine receptors and neurotransmitter transporters.
|
pubmed:affiliation |
College of Pharmacy, University of Kentucky, Rose Street, Lexington, KY 40536-0082, USA.
|
pubmed:publicationType |
Journal Article,
Research Support, N.I.H., Extramural
|